Announced
Completed
Synopsis
Temasek, a global investment company headquartered in Singapore, acquired a 30% stake in Aerogen, the world leader in acute care aerosol drug delivery. Financial terms were not disclosed. John Power, founder and CEO of Aerogen, remarked, “We are excited to realize the growth opportunities this collaboration will bring. Temasek, our partner of choice, has deep global and sector expertise, which will accelerate our market penetration.”
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.